irinotecan hydrochloride
irinotecan hydrochloride is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand names including Camptosar, Irinotecan Hydrochloride. Available dosage form: injection, solution.
Drug details
- Generic Name
- irinotecan hydrochloride
- Brand Names
- Camptosar, Irinotecan Hydrochloride
- Application Number
- NDA020571
- Sponsor
- Pharmacia & Upjohn Company LLC
- NDC Codes
- 4
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- IRINOTECAN HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE • CAMPTOSAR is indicated as a component of first-line therapy in combination with 5-fluorouracil (5-FU) and leucovorin (LV) for patients with metastatic carcinoma of the colon or rectum. • CAMPTOSAR is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy. CAMPTOSAR is a topoisomerase inhibitor indicated for: • First-line therapy in combination with 5-fluorouracil and leucovorin for patients with metastatic carcinoma of the colon or rectum. ( 1 ) • Patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy. ( 1 )